Chinese Vaccine, Among World’s Most-Used, Flops vs Omicron: Study
The vaccine made by Sinovac Biotech is one of the most widely used in the world.The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the…
UK To Recognise Covaxin, No Quarantine For Fully Vaccinated Travellers
India’s Covaxin has been to the UK’s approved list of vaccines for inbound travellers. (File)HighlightsChina’s Sinovac and Sinopharm will also be added to UK’s approved list The changes will come…
WHO Experts Recommend 3rd Dose For Over-60s Jabbed With Sinopharm, Sinovac
WHO has suggested 3rd dose for over 60 jabbed with Sinopharm, Sinovac.Geneva, Switzerland: The WHO’s vaccine advisors recommended Monday that people over 60 who have been fully immunised with China’s…
Covishield, China’s Sinovac Approved By Australia Ahead Of Border Opening
Covishield is the name of the AstraZeneca Plc shot made by Serum Institute of India (File)Australia recognized China’s Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the…
Thailand To Mix Sinovac, AstraZeneca Jabs “To Boost Protection Against Delta Variant”
A majority of Thailand’s medical and frontline workers were given Sinovac’s shots after February (File)Bangkok: Thailand’s immunisation strategy against the coronavirus will see a shot of AstraZeneca’s viral vector vaccine…
Rich nations have cornered half of future Covid-19 vaccine supply: Oxfam
A group of wealthy nations representing 13 percent of the global population have already bought up more than half of the promised doses of future Covid-19 vaccines, according to a…
वैैक्सीन बनाने की रेस में सबसे आगे चीन, पहली वैक्सीन ट्रायल के अंंतिम चरण में और दूसरी को सीमित लोगों पर इस्तेमाल की अनुमति मिली
चीन ने पहली वैक्सीन फार्मा कम्पनी सीनोवेक बायोटेक के साथ मिलकर तैयार की है, यह ट्रायल के अंतिम चरण में है दूसरी वैक्सीन चीन के पीपुल्स लिब्रेशन आर्मी मेडिकल रिसर्च…
China’s Sinovac says coronavirus vaccine has shown positive results in trials
Chinese vaccine-maker Sinovac Biotech has said its COVID-19 vaccine candidate, named CoronaVac, has elicited an immune response in phase I/II clinical trials. The Beijing-based company also said the vaccine hasn’t…
चीनी कम्पनी सिनोवेक ने कहा- हम 99% सफल होंगे, लेकिन ट्रायल के लिए हमारे यहां अब मरीज नहीं मिले रहे
बीजिंग की बायोटेक कम्पनी सिनोवेक का दावा, वैक्सीन के 100 मिलियन डोज तैयार करने का लक्ष्य है शोधकर्ताओं के मुताबिक, तीसरे दौर के लिए ट्रायल के लिए चीन में पर्याप्त…